Enliven: Clinical Cardiology and Research is an Open access, peer reviewed international journal and it aims to publish different types of articles on emerging developments and supports current and upcoming research in the field of cardiology. This journal also allows articles on clinical research in cardiology.
This journal will support the budding scientists, scholars, academicians, researchers, and students by providing Open access platform for publishing their work.
This journal will follow the peer review policies and will bode Open access in having quality research output.
This journal combines the innovative scientific ideas and ways in cardiology, clinical research and all other related disciplines to have an innovative output.
Enliven: Clinical Cardiology and Research invites articles from authors and we assure authors that articles received will be processed with the best policies and will disseminate the articles to the right field.
This journal focuses on basic, translational, and clinical research for prevention; diagnosis, and treatment of cardiovascular diseases.
This Journal will provide the complete coverage of modern practices in cardiovascular therapy.
Official Media Partners:
Global Cardiology Congress 2018 Conference will be an examination of new research Innovation in the field of Cardiology and spread the latest progressions in heart disease prevention and recovery. Discussion on new technology advancement in the field of Cardiovascular Disease, current practices in cardiovascular therapy, Heart Disease Management, Stem cell Research on heart, Silent ischemia and ischemic heart disease, Heart failure, Congestive heart failure and more. Detecting heart disease and other cardiac conditions involves a team of healthcare professionals, of which the Cardiology technologist is a key player. The global cardiology market is expected to grow at a strong CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $2,100 million by 2019. The market is mainly driven by the increasing research funding for cardiology from governments and private investors, growing demand for personalized medicine in the U.S. and Europe.
Venue: Hyatt Regency Osaka,1-13-11 Nanko-Kita, Suminoe-Ku Osaka, Japan, 559-0034 wall tension
Conference Title: International Conference on cardiology and cardiovascular medicine
Short Name: Global Cardiology Congress 2018
Date: June 18-19, 2018
Event Date: 2018-09-24 - 2018-09-26
Venue: Abu Dhabi, UAE
We are pleased to invite the contributors across the globe on its "5th World Heart and Brain conference" which is slated at Abu Dhabi, UAE during September 24-26, 2018 around the theme "Fostering Heart and brain health world-wide" "It covers topics such as Cardiology, Neurology, Medicine, Medical imaging, Nuclear cardiology, Neuroscience, Stroke, Heart disease, Interventional Cardiology, Neuron Surgeon, Brain disorders, Dementia and other related disciplines”. Our Conference will provide a perfect platform addressing: Laudable talks by the top-notch of the global scientific community Sterling workshop sessions, Remarkable Awards and Global Recognition to meritorious Researchers, Global Networking with 50+ Countries, Novel Techniques to Benefit Your Research, Global Business and Networking Opportunities, Exquisite Platform for showcasing your products and International Sponsorship
Join Heart and Brain 2018 and spend few days in amazing city of Abu Dhabi.
For more details, please visit: https://heart-brain.conferenceseries.com/
Hypertension 2018 welcomes attendees, presenters, and exhibitors from all over the world to Toronto, Canada. We are delighted to invite you all to attend and register for the “3rd Annual Conference on Hypertension and Cardiovascular Disease” which is going to be held during August 20-21, 2018 Toronto, Canada.
Hypertension 2018 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation.
PULSUS Conferences invites all the participants from all over the world to attend “4th International Heart Conference” under the theme “Innovative Forum for Cardiologists and Scholars” during September 10-11, 2018 in Singapore. This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Advanced Heart 2018 Conference is an excellent platform to discuss critically important research and to intensify collaborations and scientific research. This conference aims in gathering renowned Scientists, Professors and Research professionals across the globe under a single roof, where they discuss the research, achievements and advancements in the field of Cardiology and Health Care and to promote continuous medical education and encourage a nourishing exchange of facts and ideas about Cardiology and Heart health.
Cardiology 2018 welcomes attendees, presenters, and exhibitors from all over the world to Amsterdam, Netherlands. We are delighted to invite you all to attend and register for the "Global Congress on Cardiology and Interventional Cardiology" which is going to be held during September 17-18, 2018 Amsterdam, Netherlands.
Targeting Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9): A New Promising Approach for the Management of Hypercholesterolemia
DOI: NAAbstract View Pdf Full Text
Authors: Constantine E. Kosmas
Valve-in-valve transcatheter aortic valve concept with core valve/Evolut R©for degarded small versus bigger bioprostheses.
- ViV-TAVI with Core Valve/R determined to be safe and competent in terms of no coronary interface and very low mortality up to 3 years despite slightly higher mean transprosthetic declivity especially in very small bioprostheses.
Transcatheter aortic valve concept and off-pump coronary artery surgery: an effective hybrid method in selected patients.
- Hybrid OPCAB/MIDCAB and TAVI prove to be a safe and adequate alternative tratment option in selected higher risk patients.
Global longitudinal strain and long-term reaction in asymptomatic extractcardiac sarcoid patients with no possible cardiovascular disease.
- Among patients with extracardiac sarcoidosis and no symptoms of cardiovascular disease, alike when EF is retain, GLS seems to be actively associated with adverse future events.
Heart Rate, Beta Blocker Use, and reaction of Heart Failure with decreased Ejection Fraction.
- In a real-world analysis, high resting HR frequently in HFrEF patients and associated with injurious results. Opportunities exist to improve GDMT and achieve HR control.
A case report of Brugada-like-ST-segment altitude probably due to Cardiovascular disease vasospaam.
- This case links Brugada syndrome to coronary vasospasm. They may share identical mechanisms. Provocation test and gene test needs to be ran to distinguish both.Long-term follow-up is essential for it may bring a ominous sign for life threatening vent